The Association of Lower Levels of Baseline Proteinuria With Earlier Remission in Primary Membranous Nephropathy.

membranous nephropathy nephrotic syndrome pla2r primary membranous nephropathy secondary membranous nephropathy

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2024
Historique:
accepted: 07 06 2024
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 9 7 2024
Statut: epublish

Résumé

Aim To study the clinical profile and course and to assess the outcome of patients with biopsy-proven primary membranous nephropathy (MN). Methods This study was carried out in a tertiary care hospital between December 2017 and December 2021 on four-year retrospective biopsy-proven patients with membranous nephropathy (MN). Urinary proteins, serum albumin, and serum creatinine were the baseline investigations that were performed. Special tests were done whenever necessary. Patients were treated with a modified Ponticelli (MP) regimen whenever needed. Patients were followed up after treatment administration for a minimum of a year. Results The study was done in 48 biopsy-proven MN patients. Thirty-six patients had primary MN with a mean age of 47+/-11.7 years. The male-female ratio was 2.6:1. Hypertension was present in 39% (14 patients), microscopic hematuria in 28% (10 patients), and acute kidney injury in 22% (8 patients). The mean 24-hour urinary protein was 11.2+/-2.9 g/day. PLA2R was positive in 78% (28 patients) of primary MN patients. Spontaneous remission was noted in 13.8% (5 patients) who were treated conservatively. Spontaneous remission was associated with lower baseline proteinuria (p<0.001), higher baseline serum albumin (p

Identifiants

pubmed: 38978879
doi: 10.7759/cureus.61918
pmc: PMC11230608
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e61918

Informations de copyright

Copyright © 2024, Joseph et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Institutional Ethics Committee of Government Stanley Medical College and Hospital issued approval ECR/131/Inst/TN/2013/RR-22/20220506. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Jerry Joseph (J)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Thirumavalavan Subramanian (T)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Murugesan Vellaisamy (M)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Srinivasaprasad Nd (S)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Sujith Surendran (S)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Thirumalvalavan Kaliaperumal (T)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Poongodi Annadurai (P)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Nived Haridas (N)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Edwin Fernando (E)

Nephrology, Government Stanley Medical College and Hospital, Chennai, IND.

Classifications MeSH